The changing nature of what it means to be “diagnosed”
One of a series of posts honoring #RareDiseaseDay (Feb 28, 2015). Historically, the starting point for making a rare disease diagnosis is the patient’s clinical profile: the set of symptoms and features that together define Diamond Blackfan anemia (DBA), Niemann-Pick disease or any of a thousand other conditions. For example, anemia and problems absorbing nutrients […]
Epilepsy surgery: When it’s not good to wait
About a third of children with epilepsy do not get better with drug treatment. Many physicians are inclined to try additional drugs to control the seizures—and there are many to choose from. However, analysis of data from tens of thousands of patients suggests that if two or more well-chosen drugs have failed, and surgery is […]
Who We are
The mission of the Technology and Innovation Development Office (TIDO) is to translate the excellence of the laboratory research and clinical care at Boston Children’s Hospital into lifesaving biomedical products, devices and procedures for the public benefit.
News and Events
2015 Technology Development Fund Launch and Info Session on Feb. 23
The Technology Development Fund (TDF) invites all hospital employees with technologies that can be developed into products to apply for 2015 TDF funding.Learn more at the TDF information session on Monday, Feb. 23 11:30 am–12:30 pm in the Karp 8 conference room. Kindly RSVP to Technology.Development@childrens.harvard.edu.
Due this Friday! Pfizer CTI Call For Proposal Applications
The current cycle for Pfizer CTI's biotherapeutic and small molecule proposals is currently open. 2 page, non-confidential pre-proposals are due February 13th, 2015!